Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IDP-124
- Development stage
- Discontinued
- Lead developer
- Ortho Dermatologics
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
IDP-124 is a topical small molecule drug developed as a lotion for the treatment of moderate to severe atopic dermatitis (eczema). The drug was originally developed by Ortho Dermatologics, a division of Bausch Health Companies (formerly Valeant Pharmaceuticals International). Its precise mechanism of action remains undefined or unknown. Clinical development reached phase 3 trials in both pediatric and adult populations, but the program was discontinued before approval. There are no known brand names or approved indications for this product[1][2][3][4][5].
- Brand names
- IDP-124 Vehicle LotionIDP124 Vehicle LotionIDP 124 Vehicle Lotion
- Other names
- IDP 124IDP124IDP-124
Beyond the preview
Go deeper on IDP-124.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IDP-124.